← Leaderboards
Supriya Dinkar Mahajan
State University Of New York At Buffalo
$1,168,546
Attributed
$1,946,786
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $442.8K · FY2010–24$500K$375K$250K$125K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,946,786 · 3
By mechanism
R01$1,113,730 · 1
R21$833,056 · 2
Top collaborators
- Alexander Khmaladze3 shared
- Michelle B Visser1 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Michelle B Visser$2,431,070
- Howard K Kuramitsu$2,028,340
- Natalie Anselmi$97,681
- Ashu Sharma$8,606,006
- Megan Jones$57,866
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularIn VitroMediatingCellsInnovationBrainResponseChronicGene ExpressionBaseProtein ExpressionIn VivoStimulusDrug AbuseEventSignal TransductionNeuronsNerve DegenerationNeuroinflammationMicrogliaMicroscopyMorphologyInflammatoryDementia
Grant awards (6)
Emerging role of oral spirochetes to promote neuroinflammation and dysfunction$442,750
R21 · FY2024 · AG
A novel phase and spectroscopic imaging technique to evaluate mitochondrial dynamics$373,844
R01 · FY2021 · DA
A novel phase and spectroscopic imaging technique to evaluate mitochondrial dynamics$373,875
R01 · FY2020 · DA
A novel phase and spectroscopic imaging technique to evaluate mitochondrial dynamics$366,011
R01 · FY2019 · DA
Innovative Nanotherapy for Drug addiction.$192,181
R21 · FY2011 · DA · contact PI
Innovative Nanotherapy for Drug addiction.$198,125
R21 · FY2010 · DA · contact PI